Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -136.92% is 106% below its 5-year average of -66.38%, near the low end of its 5-year range (-136.92%–-19.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.30% below its 12-month average of -119.79%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -136.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-136.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-119.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-89.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-66.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-87.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.30%
CURRENT VS 3Y AVG
-52.28%
CURRENT VS 5Y AVG
-106.26%
CURRENT VS 10Y AVG
-55.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-284.13%
vs the sector median at left
Avita Medical Inc.
Market Cap
$322.71M
Return on Invested Capital (ROIC)
-136.92%
TTM Avg
-119.79%
3Y Avg
-89.91%
5Y Avg
-66.38%
Market Cap
$321.76M
Return on Invested Capital (ROIC)
18.15%
TTM Avg
3.75%
3Y Avg
-6.35%
5Y Avg
-21.63%
Market Cap
$324.76M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
Market Cap
$318.43M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$329.37M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$330.19M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$311.90M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$309.19M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-35.80%
3Y Avg
-1011.32%
5Y Avg
-772.02%
Market Cap
$344.04M
Return on Invested Capital (ROIC)
-30.78%
TTM Avg
-151.81%
3Y Avg
-134.98%
5Y Avg
-109.65%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $322.71M | -136.92% | -119.79% | -89.91% | -66.38% |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | 18.15% | 3.75% | -6.35% | -21.63% |
| CapsoVision, Inc. (CV)vs › | $324.76M | -164.32% | -159.25% | -125.06% | -125.06% |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | -35.92% | -35.67% | -36.59% | -30.23% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -85.56% | -114.55% | -77.72% | -63.50% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | -40.51% | -48.13% | -48.38% | -39.85% |
| Agenus Inc. (AGEN)vs › | $311.90M | N/A | -35.18% | -129.73% | -103.61% |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | -28.88% | -35.80% | -1011.32% | -772.02% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | -30.78% | -151.81% | -134.98% | -109.65% |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | -84.66% | -114.58% | -126.88% | -126.88% |
ROIC
-136.9%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -136.92% |
| 2026-03-31 | -127.41% |
| 2025-12-31 | -115.91% |
| 2025-09-30 | -94.90% |
| 2025-06-30 | -123.82% |
| 2025-03-31 | -109.90% |
| 2024-12-31 | -95.03% |
| 2024-09-30 | -92.17% |
| 2024-06-30 | -73.49% |
| 2024-03-31 | -58.41% |
| 2023-12-31 | -43.33% |
| 2023-09-30 | -52.46% |
| 2023-06-30 | -45.14% |
| 2023-03-31 | -34.42% |
| 2022-12-31 | -31.41% |
| 2022-09-30 | -33.26% |
| 2022-06-30 | -31.94% |
| 2022-03-31 | -28.62% |
| 2021-12-31 | -23.50% |
| 2021-09-30 | -19.52% |
| 2021-06-30 | -22.47% |
| 2021-03-31 | -28.80% |
| 2020-12-31 | -72.33% |
| 2020-09-30 | -72.90% |
| 2020-06-30 | -58.28% |
| 2019-12-31 | -54.46% |
| 2019-06-30 | -174.44% |
| 2019-03-31 | -191.50% |
| 2018-12-31 | -115.41% |
| 2018-09-30 | -142.68% |
| 2018-06-30 | -144.15% |
| 2018-03-31 | -134.73% |
| 2017-12-31 | -130.00% |
| 2017-09-30 | -142.51% |
| 2017-06-30 | -287.41% |
| 2017-03-31 | -336.83% |
| 2016-12-31 | -116.98% |
| 2016-09-30 | -133.11% |
| 2016-06-30 | -148.78% |
| 2016-03-31 | -174.37% |
| 2015-12-31 | -87.14% |
| 2015-09-30 | -121.35% |
| 2015-06-30 | -152.56% |
| 2015-03-31 | -206.98% |
| 2014-12-31 | -264.43% |
| 2014-09-30 | -332.67% |
| 2014-06-30 | -115.04% |
| 2014-03-31 | -139.71% |
| 2013-12-31 | -123.27% |
| 2013-09-30 | -130.82% |
| 2013-06-30 | -87.94% |
| 2013-03-31 | -93.89% |
| 2012-12-31 | -79.59% |
